If you read any research about Alzheimer’s disease, two proteins are going to be your main characters. There’s amyloid-β, which builds up and forms plaques in the brain; and there’s tau, which ...

Mount Sinai scientists analyzed over 12,000 brain proteins, uncovering how neuron–glia communication failures drive Alzheimer ...

The dementia associated Tau protein — known for its role in microtubule regulation — has now been found to also play important roles in the nerve signaling and mitochondrial function in the brain. A ...

POTOMAC, MD / ACCESS Newswire / September 24, 2025 /IGC Pharma, Inc. (NYSE American:IGC) today announced preclinical findings ...

POTOMAC, Md.--(BUSINESS WIRE)--IGC Pharma, Inc. (NYSE American: IGC) ("IGC Pharma" or the "Company") today announced preclinical research demonstrating the therapeutic potential of IGC-1C, a novel ...

Alzheimer’s disease has proved to be a tricky target, and researchers and drug developers have been pursuing effective ...

Scientists have developed a new drug that targets two key regions of the tau protein, a major contributor to Alzheimer’s disease. The drug, a peptide inhibitor called RI-AG03, successfully prevented ...

Researchers at the University of Pittsburgh have devised a biomarker test that can spot small amounts of clumping tau protein in the brain and cerebrospinal fluid, which lead to Alzheimer's disease.

A research team at the University of Cologne has made a significant breakthrough in understanding the role of the tau protein in Alzheimer's disease. Using human induced pluripotent stem cells (iPSCs) ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...